External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home Neuroscience ACTRIMS Forum 2026

ACTRIMS Forum 2026

February 05 - February 07
San Diego, USA
forum.actrims.org
We will be contributing to topics related to
Neuroscience
Add to calendar
Share feedback
Share page
-
Agenda
Medical Materials
01:45 AM
Duration 105mins San Diego, USA
Long-Term Impact on Work Productivity and Cognition With First-Line Ocrelizumab Treatment
Craveiro, Licinio; Benedict H. B., Ralph; Berger, Thomas; Bermel A., Robert; Vanopdenbosch, Ludo; Holmøy, Trygve; Clinch, Susanne; Moore, Suzanne; Killestein, Joep
Neuroscience | Multiple Sclerosis

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 105mins San Diego, USA
Ocrelizumab Reduces the Risk of Progression Independent of Relapses (PIRA): An Analysis of the Phase III OPERA Trials Using Multiple PIRA Definitions
Craveiro, Licinio; Bermel, Robert A; Lorscheider, Johannes; Butzkueven, Helmut; Wang, Qing; Jones, David; Cutter, Gary; Kappos, Ludwig
Neuroscience | Multiple Sclerosis

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 105mins San Diego, USA
Association of Composite Confirmed Disability Progression With Clinical, Biomarker and Patient-Reported Outcomes
Brownlee, Wallace; Bermel A., Robert; Ghazaleh, Naghmeh; Abdul Samad, Jad; Wang, Qing; Bonati, Ulrike; Tumani, Hayrettin; Kappos, Ludwig
Neuroscience | Multiple Sclerosis

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 105mins San Diego, USA
Delay in Progression to Key Disability Milestones With Ocrelizumab in Patients With Primary Progressive Multiple Sclerosis in the ORATORIO-HAND Study
Oh, Jiwon; Giovannoni, Gavin; Airas, Laura; Bove, Riley; Cutter, R., Gary; Hobart, Jeremy; Kuhle, Jens; Montalban, Xavier; Tur, Carmen; Wolinsky, S., Jerry; Schneble, Hans-Martin; Baldinotti, Anna; Bonati, Ulrike; Giacobino, Caroline; Wang, Qing; Craveiro, Licinio
Neuroscience | Multiple Sclerosis

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 105mins San Diego, USA
No Evidence of Disease Activity (NEDA-3) in Treatment-Naive People With Relapsing Multiple Sclerosis Treated With Intravenous or Subcutaneous Ocrelizumab: Findings of the OPERA (10 Years) and OCARINA II (2 Years) Studies
Cree, Bruce A. C; Newsome, Scott D., Cerqueira, João; Centonze, Diego; Traboulsee, Anthony; Craveiro, Licinio; Schenble, Hans-Martin; Zecevic, Dusanka; Figueirido, Catarina; Wang, Qing; Giacobino, Caroline; Selmaj, Krzysztof
Neuroscience | Multiple Sclerosis

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 105mins San Diego, USA
Intravenous and Subcutaneous Ocrelizumab Lead to Sustained Reductions in Serum Neurofilament Light Chain Levels in Treatment-Naive People With Multiple Sclerosis
Bar-Or, Amit; Krzystanek, Ewa; Kuhle, Jens; Monreal, Enric; Selmaj, Krzysztof; Craveiro, Licinio; Figueiredo, Catarina; Giacobino, Caroline; Raposo, Catarina; Shen, Yun-An; Thanei, Gian-Andrea; Newsome, Scott D
Neuroscience | Multiple Sclerosis

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 105mins San Diego, USA
Exploring the Potential of Combination Therapy to Tackle MS Progression: Design of the Phase II MINTAKA Study Evaluating the Safety, Pharmacokinetics, Pharmacodynamics and Efficacy of the Oral Monoacylglycerol Lipase Inhibitor RG6182 as an Add-On to Ocrelizumab in People With Progressive Multiple Sclerosis
Overell, James; Krumova, Petranka; Sturm, Stefan; Hubeaux, Stanislas; Magon, Stefano; Mandic, Iva; Cottreel, Emmanuelle; Portron, Agnes; Yu, Huixin; Poirier, Agnes; Hayward-Koennecke, Helen; Stroband Majid, Homa; Collin, Ludovic; Baker, Mike; Schippling, Sven; Stephan, Alexander
Neuroscience | Multiple Sclerosis

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
01:45 AM
Duration 105mins San Diego, USA
Real-World Effectiveness of Ocrelizumab in Primary Progressive Multiple Sclerosis: Insights From the MSOCR-P Cohort, a MSBase Registry Sub-Study
Craveiro, Licinio; Butzkueven, Helmut; Farr, Pamela; Ozakbas, Serkan; Laureys, Guy; Alroughani, Raed; Horakova, Dana; Rous, Zuzana; Houskova, Jana; van der Walt, Anneke; Brecl Jakob, Gregor; Kalincik, Tomas; Hradilek, Pavel; Meca-Lallana, Jose E.; Boz, Cavit; Lechner-Scott, Jeanette; Sanchez-Menoyo, Jose Luis; Buzzard, Katherine; Willekens, Barbara; Grand'Maison, Francois; Cartechini, Elisabetta; Habek, Mario; Recmanova, Eva; Yetkin, Mehmet Fatih; Stourac, Pavel; Muros-Le Rouzic, Erwan; Spelman, Tim; MSBase Investigators
Neuroscience | Multiple Sclerosis

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 105mins San Diego, USA
Real-World Effectiveness of First-Line Ocrelizumab Treatment in Relapsing Multiple Sclerosis: Insights From the MSBase OCR-R Sub-Study
Craveiro, Licinio; Butzkueven, Helmut; Farr, Pamela; Alroughani, Raed; Van Der Walt, Anneke; Kalincik, Tomas; Kermode, Allan; Lechner-Scott, Jeanette; Foschi, Mateo; Boz, Cavit; Ozakbas, Serkan; Buzzard, Katherine; Skibina, Olga; Grand'Maison, Francois; Rojas, Juan; Laureys, Guy; Ramo-Tello, Cristina; Barnett, Michael; Besora, Sarah; Willekens, Barbara; Muros-Le Rouzic, Erwan; Spelman, Tim; MSBase Investigators
Neuroscience | Multiple Sclerosis

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 105mins San Diego, USA
Safety of Ocrelizumab vs Other Disease-Modifying Therapies in People With Relapsing Multiple Sclerosis Aged 55 Years or Older
Craveiro, Licinio; Butzkueven, Helmut; Buttman, Mathias; Duran-Pacheco, Gonzalo Christian; El Azouzzi, Bouchra; Elberling, Frederik; Ferreira, Germano; Flavia Mouresan, Elena; Glaser, Anna; Hillert, Jan; Iaffaldano, Pietro; Lucisano, Giuseppe; Muros-Le Rouzic, Erwan; Rollot, Fabien; Trojano, Maria; Vukusic, Sandra; Zhu, Chao; Ziemssen, Tjalf; Magyari, Melinda
Neuroscience | Multiple Sclerosis

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
08:27 PM
Duration 13mins San Diego, USA
Efficacy and Safety of Fenebrutinib vs Ocrelizumab in Primary Progressive Multiple Sclerosis: Primary Results of the Phase III FENtrepid Study
Bar-Or, Amit; Oh, Jiwon; Giovannoni, Gavin; Sormani, Maria Pia; Weber, Martin S; Stoll, Sharon; Nicholas, Jacqueline A; von Büdingen, H.-Christian; Lopez, Jon; Roberts, Louise; Triyatni, Miriam; Qi, Qi; Ratchford, Jack; Napieralski, Julie; Goodyear, Alexandra; Hauser, Stephen L; Kappos, Ludwig
Neuroscience | Multiple Sclerosis

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Coming soon

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.